Both in Biotechnology
INmune Bio vs Elutia
Over the past year INMB returned −22.7% and ELUT returned −17.4%; their daily moves had a correlation of 0.05.
INMB −22.7% ELUT −17.4%Growth of $1, one year, split-adjusted
| Metric | INMB | ELUT |
|---|---|---|
| Price | $1.33 | $0.7596 |
| Market cap | $41.2M | $33.6M |
| Today | +0.76% | −6.59% |
| 1 month | −28.9% | −2.2% |
| 6 months | −12.5% | −25.5% |
| Year to date | −14.7% | +9.7% |
| 1 year | −26.1% | −18.8% |
| Revenue growth (YoY) | — | −11.6% |
| Gross margin | — | 59.6% |
| Net margin | — | −315.0% |
| P/E (TTM) | — | 0.6× |
| Price / sales | — | 2.8× |
| Net cash | $18.4M | $19.9M |
| Dividend yield | — | — |
| Volatility (60d) | 65.4% | 62.3% |
| Short % of float | 11.7% | 0.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).